ABSTRACT In the rabbit isolated thoracic aorta, WB 4101 and 5-methylurapidil dose-dependently shifted the concentration-response curves for norepinephrine to the right. Schild plots showed that the inhibition of responses for WB 4101 and 5-methylurapidil was biphasic, implying that norepinephrine acted through two receptor populations. Clonidine produced a concentration-dependent contraction in the isolated rabbit thoracic aorta. WB 4101 and 5-methylurapidil antagonized the contractions for cloni dine, and the Schild plot to both antagonists against clonidine yielded a monophasic slope. Schild plots of the results obtained from the inhibition by WB 4101 and 5-methylurapidil for norepinephrine in strips pretreated with chloroethylclonidine yielded a straight line with a slope of unity. Specific binding of [3H]prazosin in the aortic membrane preparations was saturable. The Hill coefficient obtained from the inhibition curves for clonidine was significantly different from unity. Clonidine interacted with two binding sites labelled by [3H]prazosin, but the low affinity site was completely eliminated by pretreat ment with 10,uM chloroethylclonidine. These results suggest that the subtype activated by nor epinephrine is different from that activated by clonidine, and that norepinephrine-induced contraction through both a IA and a ,B-subtypes and clonidine through only the a IA-subtype in the rabbit thoracic aorta.
a 1-Adrenoceptor subtypes play an important role in sympathetic nerve transmission. Two major subtypes (a lA and a113) have been identified by pharmacological studies (1 5) . The a 1A-subtype has higher affinity than the a113-subtype for antagonists such as WB 4101, 5 methylurapidil, (+)-niguldipine and phentolamine (6 8) . Moreover, an alkylating analog of clonidine irre versibly inactivates the a 1B-adrenoceptor (2, 9) , while an alkylating analog of prazosin, SZL-49, irreversibly in activates the a 1A-adrenoceptor (10) (11) (12) . Flavahan and Vanhoutte (13) also suggested that there are two dis tinct subtypes of a 1-adrenoceptors that are distinguish able by their affinities for prazosin and yohimbine in blood vessels. These findings are in agreement with the results of Takayanagi et al. (14) who demonstrated two subtypes of a 1-adrenoceptors in arteries and compared them with affinities for prazosin and its derivatives. Muramatsu et al. (15) proposed that a 1-adrenoceptors in blood vessels can be divided into three subtypes des ignated as a 1H, a 1L, and a IN by their antagonist affin ity and susceptibility to chloroethylclonidine or nifedi pine. Molecular cloning studies have also revealed heterogeneity in a 1-adrenoceptors (16) (17) (18) (19) . In the pul monary arteries of rabbits and dogs, Holck et al. (20) and Flavahan et al. (21) showed that prazosin antago nized the contractile responses to methoxamine, cloni dine and phenylephrine with two different affinities. Multiple affinity sites of a 1-adrenoceptor have also been demonstrated in binding studies with vascular tis sues, including the rat, rabbit and bovine aorta (10, (22) (23) (24) (25) . In the rabbit blood vessels, these subtypes of a 1-adrenergic receptors may couple with different signal transduction mechanisms; chloroethylclonidine-sensitive a 1-adrenoceptors stimulate phosphatydil inositol hy drolysis and cause an increase in intracellular functional Ca t+, whereas chloroethylclonidine insensitive a 1-adre noceptors do not stimulate inositol formation and cause physiological responses predominantly dependent on the influx of extracellular Ca 2+ (2) . In rat hepatocytes, a 1-adrenoceptors are closely linked to phosphatydil inositol hydrolysis and Ca 2+ release from intracellular stores and activate phosphorylase (8) . There are two a 1-adrenoceptor subtypes, a 1A and a 1B, in the rabbit aortic smooth muscle (26, 27) . Furthermore, Takayanagi et al. (27) reported that phenylephrine, a full agonist, induced contraction through both a lA and a lB-sub types and tizanidine through only the a lA-subtype, suggesting a contraction different from that activated by the partial agonists. To obtain additional evidence we did further studies on the modes of action of norepi nephrine, a full agonist and clonidine, a partial agonist.
To determine the detailed differences between con tractile responses to norepinephrine and clonidine, their antagonist affinity and susceptibility to WB 4101, 5 methylurapidil or chloroethylclonidine were studied in thoracic strips; competition studies of clonidine on [3H]prazosin binding were also conducted.
MATERIALS AND METHODS

General
Male albino rabbits weighing 2.0 3.0 kg were killed by bleeding from the neck. The thoracic aorta was quickly removed and dissected free of excess fat and connective tissue in oxygenated Krebs solution of the following composition: 118 mM NaC1, 1.2 mM MgC12, 2.5 mM CaC12, 1.2 mM KH2PO4, 25 mM NaHCO3 and 11.0 mM glucose dissolved in distilled water (pH = 7.4 at 37°C). The solution contained propranolol (10-6M), yohimbine (3 X 10-7 M), desmethylimipramine (10-7M) and normetanephrine (10-6M) to block ,8-adreno ceptors and a 2-adrenoceptors and to inhibit neural and nonneural uptake of catecholamine, respectively. The arteries used were thoracic aorta. These were cut into helical strips about 10 mm in length and 2 mm in width. In order to avoid the possible involvement of endothelium-derived relaxing factor in the mechanical response, the endothelial cells were removed by gently rubbing the artery with filter paper, and the functional loss of endothelial cells was confirmed by the loss of the relaxation response to acetylcholine (10-6M) in norepinephrine-precontracted aorta. Effects of chloro ethylclonidine, an irreversible antagonist of a 1-adreno ceptors, were tested. After determination of the control concentration-response curves of agonists, the strips were treated with chloroethylclonidine (10-4M) for a total of 60 min; following the initial application, this antagonist was renewed every 10 min at the same time. The concentration response curves of agonists were de termined after sufficient repetitions had been made so that constant curves were established.
Mechanical responses
The strips were suspended in a 20-m1 organ bath fill ed with Krebs solution gassed with a mixture of 95% 02 and 5% CO2 and maintained at 37°C. The response to an agonist was isometrically recorded under a resting tension of 1 g for all strips. Strips were first allowed to equilibrate for 90 min, contracted by norepinephrine (10-5 M) , and then allowed to equilibrate for 30 min after washout. This was repeated until two successive contractions of approximately equal size had been obtained.
The competitive antagonistic activities were expressed as pA2 values (negative logarithms of the dissociation constant). After determination of control concentration response curves, the strips were equilibrated with a competitive antagonist for 10 min. Concentration-re sponse curves were then obtained in the presence of the antagonist and the procedure repeated with a high (either 3 or 10-fold) concentration of the antagonist in the same preparation. After determination of the con trol, concentration -response curves of norepinephrine were determined. Curves were nearly superimposable and changes in sensitivity, sensitization, or desensitiza tion were minimal (data not shown). The pA2 values were calculated according to the method of Arunlak shana and Schild (28) .
Membrane preparation
Tissues were carefully cleaned of the adventitia and adherent connective tissues and the endothelium. The tissues were homogenized with a Teflon-glass homog enizer in 100 vol. of ice-cold buffer (5 mM Tris HCI, 0.25 M sucrose, pH 7.4) and using a polytron (setting 8, 15 sec X 2). The homogenate was filtered through four layers of cheesecloth and centrifuged at 5,000 X g for 20 min at 4°C. The supernatant was centrifuged at 100,000 X g for 60 min at 4°C. The pellet was resus pended in the same volume of buffer (50 mM Tris HCI, 1 mM EGTA, 1 mg/I of trypsin inhibitor and 1 mg/1 of leupeptin, pH 7.4), incubated for 10 min at 37°C, and centrifuged again as described above. In all membrane preparation procedures, ice-cold buffers were used. The final pellet was resuspended in assay buffer (50 mM Tris HC1, pH 7.4) and used for the binding assay.
[3H]Prazosin binding Membrane prepared from rabbit thoracic aorta was incubated with 0.2 nM [3H]prazosin in Krebs buffer for 30 min at 32°C. The reaction was terminated by rapid filtration (Cell Harvester, Brandel Co., Gaithersburg, MD) through Whatman GF/B glass fiber filters, and the filters were rinsed 3 times with 4 ml of ice-cold buff er. Membrane bound radioactivity was extracted from the filters overnight in scintillation fluid, and the radioactivity was determined in a liquid scintillation counter. Specific [3H]prazosin binding was determined experimentally from the difference between counts in the absence and presence of 10,uM phentolamine. All assays were conducted in duplicate. The apparent dis sociation constant (KD) and Bmax for [3H]prazosin were estimated by Scatchard analysis of the saturation data over a concentration range of 0.01 to 1.0 nM (29) . The ability of antagonists to inhibit specific [3H]prazosin binding was estimated by the IC50 value, which was the molar concentration of unlabeled drug necessary to dis place 50% of the specific binding (determined by log probit analysis). The value of the inhibition constant K; was calculated from the equation K; = IC50/(1 + L/KD), where L equals the concentration of [3H]prazosin (30) . The Hill coefficient for the saturation data of [3H]prazosin and inhibition by a drug were obtained by Hill plot analysis. Data obtained from competition stud ies were analyzed by the weighted least-squares itera tive curve fitting program LIGAND (31) . The data were first fitted to a one and then a two-site model, and if the residual sums of squares were statistically less for a two-site fit of the data than for a one-site, as de termined by an F-test comparison, then the two-site model was accepted. P values less than 0.05 were consi dered significant.
Statistical analyses
All numerical data are expressed as the mean ± S.E. with the number of observations. Values were consi dered to be significant when the P value was less than 0.05 by Student's t-test or Duncan's new multiple range test as appropriate.
Drugs
The following drugs were used: (-)-norepinephrine bitartrate (Wako-Junyaku, Osaka, Japan); clonidine hydrochloride (Nacalai, Kyoto, Japan); WB 4101 and chloroethylclonidine (Research Biochemicals Inc., Natick, MA); desmethylimipramine hydrochloride, (± )-normetanephrine hydrochloride, (± )-propranolol hydrochloride, and yohimbine hydrochloride (Sigma), all in powder form; and [3H]prazosin (specific activity 82 Ci/mmol, NEN, Boston, USA). Other chemicals used were of analytical grade.
RESULTS
Effects of WB 4101 and 5-methylurapidil on the con centration-response curves for norepinephrine and cloni dine
In the thoracic aorta, norepinephrine and clonidine elicited concentration-dependent contractions. pD2 values estimated from the concentration-response curves for these substances were 7.08 ± 0.04 and 5.51 ± 0.06, respectively, and the intrinsic activity (i.a.) of clonidine was 0.53 ± 0.04. WB 4101 and 5-methylurapi dil shifted the concentration-response curves for nor epinephrine and clonidine to the right in a parallel man ner (Figs. IA, B and 2A, B) . Schild plots of the results obtained from the inhibition by WB 4101 and 5-methyl urapidil for norepinephrine yielded a slope significantly different from unity (0.76 ± 0.07 and 0.48 ± 0.04), sug gesting that norepinephrine acted through two receptor populations at least. However, the Schild regression obtained from the results of the antagonism between these antagonists and clonidine yielded a straight line with a slope of unity (0.99 ± 0.07 and 0.93 ± 0.04), suggesting a simple competitive antagonism. The pA2 values for WB 4101 and 5-methylurapidil against cloni dine were 9.04 ± 0.03 and 8.97 ± 0.06, respectively.
Effects of WB 4101 and 5-methylurapidil on the con centration-response curves for norepinephrine after chloro ethylclonidine pretreatment
The pretreatment of thoracic aorta strips with chloro ethylclonidine (10-4 M) inhibited contractile responses of thoracic aorta for norepinephrine, but chloroethyl clonidine (10-5 M) only shifted the curve for nor epinephrine (Fig. 3A) , suggesting the possibility that there are some spare receptors for the drugs. However, the same pretreatment of the strips with chloroethylclo nidine did not effect contractile responses of aorta for clonidine (Fig. 313) . Concentration-response curves for norepinephrine were shifted by WB 4101 and 5-methyl urapidil in a parallel manner (Fig. 4A, B) . Schild plots of these results yielded straight lines with a slope of unity (0.95 ± 0.06), suggesting a competitive antago nism. The pA2 values for WB 4101 and 5-methylurapidil against norepinephrine were 8.86 ± 0.06 and 8.89 ± 0.04, respectively. ficantly different from unity, suggesting that this agent interacts with more than two sites for [3H]prazosin. Chloroethylclonidine-pretreatment in the tissue partly eliminated the site for clonidine (Fig. 5, Table 1 ). Table 1 . Clonidine competition for [3H]prazosin binding sites to membrane preparations from rabbit thoracic aorta DISCUSSION a i-Adrenoceptors have recently been classified into a IA and a iB-subtypes (1). There is good evidence to suggest that imidazolines and phenethylamines interact differently with a I-adrenoceptors (32-34). Takayanagi et al. (27) reported that characterization of a I adrenergic partial agonists such as tizanidine for con tractile responses showed them to be different from that of full agonists such as phenylephrine using the method of Furchgott with phenoxybenzamine. We therefore examined the possibility that clonidine may interact in a selective manner with these a I-adreno ceptors. We also determined the effect of subtype selective alkylating agents such as chloroethylclonidine on the functional responses and binding characteristics of the full agonist and the partial agonist.
In the thoracic aorta, the concentration-response curve of clonidine was shifted in a parallel manner by WB 4101 and 5-methylurapidil, a competitive inhibitor that can distinguish a IA and a IB-adrenoceptor sub types. The Schild plots of the results obtained from the antagonism yielded a straight line with a slope of unity. However, the Schild regressions of the results obtained from the antagonism between these antagonists and norepinephrine had a slope significantly different from unity (0.76 ± 0.07 and 0.48 ± 0.04, respectively). These results suggest that the antagonism between these antagonists and a partial agonist such as clonidine was a simple competitive antagonism, while the anta gonism between these antagonists and a full agonist such as norepinephrine was not a simple competitive one. These findings are in good agreement with the dif ferences in a 1-adrenoceptor mechanisms for phenyl ephrine and tizanidine in the rabbit thoracic aorta and common iliac artery previously reported by Takayanagi et al. (27) . pA2 values for WB 4101 and 5-methylurapi dil against clonidine were 9.04 ± 0.03 and 8.97 ± 0.06, respectively. Concentration-response curves for nor epinephrine in aorta strips after chloroethylclonidine (10-'M) pretreatment were shifted by WB 4101 and 5 methylurapidil in a parallel manner (Fig. 2A, B) . Schild plots of these results yield straight lines with a slope of unity. The pA2 values for these antagonists against norepinephrine were 8.86 ± 0.06 and 8.89 ± 0.04, re spectively, similar to the results with clonidine. Satoh et al. (24) , using single cells prepared from the rabbit thoracic aorta, reported that WB 4101 and 5-methyl urapidil interact with at least two sites labeled by [3H]prazosin, and chloroethylclonidine-sensitive and -in sensitive [3H]prazosin binding sites correspond to those with low (pK, --8) and high affinity (pK; 9) for WB 4101 and low (pK, --8) and high affinity (pK; --9) for 5-methylurapidil, respectively. Furthermore, Satoh et al. (24) and other investigators (35, 36) suggested that the chloroethylclonidine -insensitive sites, which were high affinity sites obtained from competition curves of these antagonists on [3H]prazosin binding, corres ponded to the a 1A-adrenoceptor subtypes obtained from responses for clonidine and norepinephrine in chloroethylclonidine-pretreated tissues. In the present studies, the pA2 values were in close agreement with the pK; values of high affinity sites of a 1A-adreno ceptors that they reported. These findings suggest that a full agonist such as norepinephrine induced contrac tion through both a 1A and a 1B-subtypes and clonidine, through only the a IA-subtype.
Chloroethylclonidine has no effect on the a lA-sub type, but produces a large reduction in the number of a 1B-adrenoceptor sites (2, 9, 37) . In this report, we show that clonidine interacted with high and low affin ity at the [3H]prazosin binding sites (Fig. 5 and Table  1) , and chloroethylclonidine eliminated only the low affinity sites for clonidine. The actions of chloroethyl clonidine on the displacement curve of clonidine also support the idea that clonidine interacts with high affin ity at the a IA and with low affinity at the a 1B-adre noceptor subtype. However, the results with clonidine obtained from contraction studies indicated that this substance interacted with only one a 1-adrenoceptor site. These different findings in contraction and binding studies initially seems contradictory. Takayanagi et al. (38) reported that isolated rabbit iris dilator strips were contracted by norepinephrine but not by methoxamine, clonidine or tizanidine, and that the pA2 values for WB 4101 and 5-methylurapidil were significantly smaller than those reported in the rat renal artery (39), thoracic aorta (26) , and rabbit bronchus (3) , where the a IA-sub type is predominant, suggesting that the rabbit iris dila tor contains primarily the a 1B-subtype. Thereafter clo nidine and tizanidine did not contract the rabbit iris dilator but shifted the curve for norepinephrine in a par allel manner, suggesting that they interact with the a 1B-subtype and act as competitive antagonists in the iris dilator. In the displacement studies of the [3H]prazosin binding by the al-full agonist phenyl ephrine, this agent also interacted with at least two affinity sites. The high affinity site (a 1A-subtype) of the displacement curve by phenylephrine was not affected by chloroethylclonidine (10-4 M) and exhibited a spe cific binding of 20.48 ± 2.52% (n = 6). The percentage of the high affinity site of clonidine (13.1 ± 1.49%, n = 4) in the present results is smaller than that obtained using phenylephrine. However, percentages of the high affinity site (a 1A-subtype) displaced by the a lA-anta gonists WB 4101 and 5-methylurapidil were 15.5 ± 4.01 and 16.4 ± 2.40%, respectively (24) . These values were closely similar to that of clonidine. These findings sup port that the [3H]prazosin binding sites of the high affinity for clonidine in the membrane preparation of rabbit thoracic aorta correspond to the a1A-adreno ceptor subtype, and 10-20% of the al-adrenoceptor is equal to that of the a 1A-adrenoceptor subtype. In the binding data of the present studies, the low affinity site interacting with clonidine was chloroethylclonidine sensitive, suggesting that this site is the a 1B-subtype, and that the chloroethylclonidine-insensitive high affin ity site interacting with clonidine is the a 1A-subtype. These findings strongly suggest that despite clonidine interacting with both a 1A and a 1B-adrenoceptor sub types, it causes contraction through only the a IA-sub types.
Takayanagi et al. (40, 41) reported similar findings for the muscarinic cholinoceptors of intestinal smooth muscles of guinea pigs. Two different subtypes of M3 receptors were identified using propylbenzilylcholine mustard (PrBCM), an irreversible muscarinic antago nist: PrBCM-sensitive and -resistant cholinoceptors. The full agonists contract the smooth muscles through both PrBCM-sensitive and -resistant ones, while the partial agonists produce the contraction through the activation of PrBCM-sensitive ones. The present results together with the findings of Takayanagi et al. (40, 41) suggest the possibility that 19-chloroethylamines such as chloroethylclonidine and PrBCM discriminate receptor subtypes.
In summary, the subtype activated by norepinephrine is distinct from that activated by clonidine, and there fore the pharmacological characterization of responses differs for full and partial agonists in the rabbit thoracic aorta.
